Effect of electroacupuncture on the conduction velocity and microstructure of the sciatic nerve in rats with experimental diabetic peripheral neuropathy

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 16, 2007, Pages 3069-3073

  Zhang, Qiu Juan ^a   Shi, Yin ^a   Zhang, Yun Yun ^a   Dong, H S ^a   Zheng, M ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; DIET RESTRICTION; ELECTROACUPUNCTURE; GLUCOSE BLOOD LEVEL; MALE; MORPHOLOGY; MOTOR NERVE CONDUCTION; MYELINATED NERVE; NERVE CONDUCTION; NONHUMAN; RAT; SCIATIC NERVE; SENSORY NERVE CONDUCTION; STREPTOZOCIN DIABETES; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 34250316559     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chinese source.
2. Chinese source.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Kalichman MW, Dines KC, Bobik M, et al. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozocin. Brain Res 1998;810(1-2):130-137
7. Hratzberger P, Walter DH, Rittig K, et al. Reversal of experimental diabetic neuropathy by VEGF gene tranfer. J Clin Invest 2001;107 (9): 1083-1092
8. Nangle MR, Gibson TM, Cotter MA, et al. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med 2006;72(6):494-500
9. Ziegler D, Siekierka-Kleiser E, Meyer B, et al. Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy. Diabetes Care 2005;28(5):1169-1174
10. Simmons Z, Feldman EL. Update on diabetic neuropathy. Curr Opin Neurol 2002;15(5):595-560
11. Chinese source.
12. Gryz EA, Szermer P, Galicka-Latala D, et al. Diagnosis and assessment of diabetic nephropathy. Literature review and authors observations. Przegl Lek 2004;61(1):25-29
13. Calcuff NA, Dines KC, Cesena RM. Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism 1998;47(6):650-656
14. Pop-Busui R, Marinescu V, Van Huysen C, et al. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acety-L-carnitine administration. Diabetes 2002;51(8):2619-2628
15. Laurie G, Lombardi R, Borgna M, et al. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 2005;10(2):202-208
16. Sima AA, Zhang WX, Tze WJ, et al. Diabetic neuropathy in STZ-induced diabetic rat and effect of allogeneic islet cell transplantation morphometric analysis. Diabetes 1998;37(8):1129-1136
17. Nardone A, Schieppati M. Group II spindle fibres and afferent control of stance. Clues from diabetic neuropathy. Clin Neurophysiol 2004;115(4): 779-789
18. Oltman CL, Coppey LJ, Gellett JS, et al. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 2005;289(1):E113-122
19. Apfel SC. Neurotrophic factors in the therapy of diabetic. Am J Med 1999;107(2B):S34-S42
20. Chinese source.
21. Chinese source.